Study on the Prevention of Recidivism and the Consequences of Sexual Violence Suffered by Female Asylum Seekers in France
PREVISEDA
2 other identifiers
observational
675
1 country
6
Brief Summary
Women seeking asylum (WSA) are overexposed to sexual violence (SV) in their countries of origin, along migration routes, and within host countries. This overexposure does not cease upon arrival in host countries; on the contrary, the first months following arrival are characterised by heightened vulnerability, with an increased incidence of sexual violence, particularly among women with a prior history of victimisation. Sexual violence has major consequences on physical health, mental health, quality of life, and healthcare utilisation, and generates substantial individual and societal costs. International organisations, including the United Nations High Commissioner for Refugees, have identified the prevention of sexual violence and the improvement of care for survivors as public health priorities. Previous work suggests that addressing sexual violence within primary care, when embedded in a comprehensive, culturally informed, and coordinated approach integrating medical, psychological, social, and medico-legal dimensions, may contribute to preventing the occurrence or recurrence of sexual violence in host countries. However, no comparative study has yet evaluated the effectiveness of such a coordinated model of care on the prevention of sexual violence among women seeking asylum, nor assessed its efficiency or transferability. The primary objective of this study is to evaluate the effectiveness of a coordinated, transcultural, multidisciplinary outpatient care model on the prevention of sexual violence occurring in host European countries among women seeking asylum.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2026
Typical duration for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2026
CompletedFirst Posted
Study publicly available on registry
March 17, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2028
March 19, 2026
March 1, 2026
2 years
February 16, 2026
March 17, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Occurrence of sexual violence within 12 months after inclusion
The primary outcome is the occurrence of sexual violence during the first 12 months following inclusion. Sexual violence is defined as the occurrence of at least one of the following events: rape, attempted rape, sexual assault, or sexual exhibition, as assessed through structured interviews administered at follow-up visits.
12 months after inclusion
Secondary Outcomes (46)
Occurrence of rape within 12 months after inclusion
12 months after inclusion
Occurrence of sexual violence between 12 and 18 months after inclusion
12 to 18 months after inclusion
Occurrence of rape between 12 and 18 months after inclusion
12 to 18 months after inclusion
Measurement and Assessment of somatic symptoms
at Baseline
Measurement and Assessment of somatic symptoms
at 3 months
- +41 more secondary outcomes
Study Arms (2)
Coordinated care model
The coordinated outpatient care model is initiated through early identification at reception platforms by a dedicated mobile team and delivered over 12 months. It is based on proactive detection of sexual violence and structured coordination of care aimed at addressing its consequences and preventing recurrence. Through this coordination, the model aims to improve early access to care, continuity of follow-up, patient engagement, and effective mobilisation of existing services, including primary care, mental health services, sexual and reproductive health services, social support, and legal assistance when required.
Comparator - Usual care
Participants in the comparator group receive usual care as implemented locally, which may include access to emergency or institutional services, primary care, or specialised structures, but without systematic coordination or proactive outreach.
Interventions
The care coordinator ensures organisation of the care pathway, liaison between professionals, and longitudinal follow-up in collaboration with a general practitioner.
The health mediator facilitates communication, supports participants in navigating healthcare and social systems, and helps reduce linguistic, cultural, and administrative barriers.
Depends on asylum seekers' individual initiatives
Systematically initiated from registration at the first reception centre (PADA)
Irregular, often interrupted due to precarious living conditions
Eligibility Criteria
Female seeking asylum in France
You may qualify if:
- Woman seeking asylum in France
- Self-identified female gender.
- Age ≥ 18 years.
- Received study information and provided informed consent to participate
You may not qualify if:
- Re-examination of a previous asylum application.
- Major cognitive impairment (e.g. dementia or intellectual disability) preventing reliable collection of study outcomes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Maison de Santé de Saint André
Bordeaux, France
MSP soins premiers Villeurbanne Est
Lyon, France
Maison de Santé PEYSSONEL
Marseille, France
Maison de Santé Butte Sainte Anne
Nantes, France
MSP Mathagon
Paris, France
Maison de santé Bonnefoy Périole Roseraie
Toulouse, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
François Crémieux
AP-HM
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 16, 2026
First Posted
March 17, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
April 1, 2028
Study Completion (Estimated)
September 1, 2028
Last Updated
March 19, 2026
Record last verified: 2026-03